20-610048-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004609.4(TCF15):c.190G>A(p.Gly64Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000591 in 1,133,188 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G64D) has been classified as Uncertain significance.
Frequency
Consequence
NM_004609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000958 AC: 14AN: 146180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00254 AC: 2AN: 788Hom.: 0 AF XY: 0.00361 AC XY: 2AN XY: 554
GnomAD4 exome AF: 0.0000537 AC: 53AN: 986908Hom.: 2 Cov.: 61 AF XY: 0.0000560 AC XY: 26AN XY: 464550
GnomAD4 genome AF: 0.0000957 AC: 14AN: 146280Hom.: 0 Cov.: 32 AF XY: 0.000126 AC XY: 9AN XY: 71224
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.190G>A (p.G64S) alteration is located in exon 1 (coding exon 1) of the TCF15 gene. This alteration results from a G to A substitution at nucleotide position 190, causing the glycine (G) at amino acid position 64 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at